Epocrates, Inc. (Epocrates) is a provider of mobile drug reference tools and electronic health records to healthcare professionals and interactive services to the healthcare industry. As of December 31, 2011, its user network consists of well over one million healthcare professionals, including approximately 340,000, or more than 50% of United States physicians. The Company offers its products on major United States mobile platforms, including Apple iOS, Android and BlackBerry. Epocrates operates in two segments: Subscriptions and Interactive Services, and Electronic Health Records. It uses brand names include DocAlert, Epocrates, Epocrates Honors, Epocrates ID, Epocrates Lab, Epocrates MedTools, Epocrates Rx, Epocrates Rx Pro, Epocrates Dx, Epocrates QuickSurvey, Epocrates QuickRecruit, Epocrates MedInsight, EssentialPoints and MedCafe. In October 2011, it launched a redesign of the drug reference tool to create a new platform that provides healthcare professionals.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
Phone+1-415-4163500
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
OptionableNot Optionable
Epocrates (NASDAQ:EPOC) Frequently Asked Questions
What is Epocrates' stock symbol?
Epocrates trades on the NASDAQ under the ticker symbol "EPOC."
Has Epocrates been receiving favorable news coverage?
Media coverage about EPOC stock has trended very positive on Tuesday, according to InfoTrie. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Epocrates earned a news sentiment score of 3.2 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 4.0 out of 10, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.
How do I buy shares of Epocrates?
Shares of EPOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Epocrates' official website?
How can I contact Epocrates?
Epocrates' mailing address is 50 Hawthorne, SAN FRANCISCO, CA 94105, United States. The company can be reached via phone at +1-415-4163500.
MarketBeat Community Rating for Epocrates (NASDAQ EPOC)
MarketBeat's community ratings are surveys of what our community members think about Epocrates and other stocks. Vote "Outperform" if you believe EPOC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EPOC will underperform the S&P 500 over the long term. You may vote once every thirty days.
